2682 Federal Register / Vol. 63, No. 11 / Friday, January 16, 1998 / Notices

FEDERAL EMERGENCY

MANAGEMENT AGENCY

[FEMA–1194–DR]

The Commonwealth of the Northern

Mariana Islands; Amendment to Notice

of a Major Disaster Declaration

AGENCY: Federal Emergency

Management Agency (FEMA).

ACTION: Notice.

SUMMARY: This notice amends the notice

of a major disaster for the

Commonwealth of the Northern Mariana

Islands (FEMA–1194–DR), dated

December 24, 1997, and related

determinations.

EFFECTIVE DATE: January 2, 1998.

FOR FURTHER INFORMATION CONTACT:

Madge Dale, Response and Recovery

Directorate, Federal Emergency

Management Agency, Washington, DC

20472, (202) 646–3260.

SUPPLEMENTARY INFORMATION: Notice is

hereby given that the incident period for

this disaster is closed effective

December 17, 1997.

(Catalog of Federal Domestic Assistance No.

83.516, Disaster Assistance)

Lacy E. Suiter,

Executive Associate Director, Response and

Recovery Directorate.

[FR Doc. 98–1143 Filed 1–15–98; 8:45 am]

BILLING CODE 6718–02–P

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 10:00 a.m., Wednesday,

January 21, 1998.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, N.W., Washington, D.C. 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any matters carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: January 14, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–1222 Filed 1–14–98; 11:23 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Health Care Policy and

Research

Meeting of the National Advisory

Council for Health Care Policy,

Research, and Evaluation

AGENCY: Agency for Health Care Policy

and Research, HHS.

ACTION: Notice of public meeting.

SUMMARY: In accordance with section

10(a) of the Federal Advisory Committee

Act, this notice announces a meeting of

the National Advisory Council for

Health Care Policy, Research, and

Evaluation.

DATES: The meeting will be held on

Thursday, February 12, 1998 from 9:00

a.m. to 4:00 p.m.

ADDRESSES: The meeting will be held at

the Natcher Conference Center, National

Institutes of Health, 45 Center Drive,

Bethesda, MD 20892.

FOR FURTHER INFORMATION CONTACT:

Nancy Foster, Coordinator of the

Advisory Council at the Agency for

Health Care Policy and Research, 2101

East Jefferson Street, Suite 502,

Rockville, MD 20852, (301) 594–1349

ext. 1307.

If sign language interpretation or other

reasonable accommodation for a

disability is needed, please contact

Linda Reeves, Assistant Administrator

for Equal Opportunity, AHCPR, on (301)

594–6655 ext. 1055 no later than

February 8, 1998.

SUPPLEMENTARY INFORMATION:

I. Purpose

Section 921 of the Public Health

Service Act (42 U.S.C. 299c) establishes

the National Advisory Council for

Health Care Policy, Research, and

Evaluation. The Council provides

advice to the Secretary and the

Administrator, Agency for Health Care

Policy and Research (AHCPR), on

matters related to AHCPR activities to

enhance the quality, appropriateness,

and effectiveness of health care services

and access to such services through

scientific research and the promotion of

improvements in clinical practice and

in the organization, financing, and

delivery of health care services.

The Council is composed of members

of the public appointed by the Secretary

and Federal ex-officio members.

II. Agenda

On Thursday, February 12, 1998, the

meeting will begin at 9:00 a.m., with the

call to order by the Council Chairman.

The Administrator, AHCPR, will update

the status of current Agency funding,

programs, and initiatives. The Council

will then discuss strategic directions for

the Agency, ethical dilemmas in health

services research, and how to assure

AHCPR research is meeting the needs of

clinicians.

The meeting will adjourn at 4:00 p.m.

Agenda items are subject to change as

priorities dictate.

Dated: January 9, 1998.

John M. Eisenberg,

Administrator.

[FR Doc. 98–1107 Filed 1–15–98; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Arthritis Advisory Committee; Notice

of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). The meeting is open to the

public.

Name of Committee: Arthritis

Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on February 20, 1998, 8 a.m. to 5

p.m.

Location: Holiday Inn, Versailles

Ballrooms I and II, 8120 Wisconsin

Ave., Bethesda, MD.

Contact Person: Kathleen R. Reedy or

LaNise S. Giles, Center for Drug

Evaluation and Research (HFD–21),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–443–5455, or FDA Advisory

Committee Information Line, 1–800–
Federal Register / Vol. 63, No. 11 / Friday, January 16, 1998 / Notices 2683

741–8138 (301–443–0572 in the

Washington, DC area), code 12532.

Please call the Information Line for upto-date information on this meeting.

Agenda: The committee will discuss

preliminary planning of a claims

structure for a future guidance for the

development of drugs, biologics, and

devices for the treatment of

osteoarthritis.

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by February 13, 1998. Oral

presentations from the public will be

scheduled between approximately 8

a.m. and 9 a.m. Time allotted for each

presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before February 13, 1998, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: January 9. 1998.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 98–1083 Filed 1–15–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Advisory Council on Drug

Abuse, National Institute on Drug Abuse

(NIDA) on February 3–4, 1998, at the

Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

On February 3, from 9 a.m. to 4 p.m.,

in accordance with provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. and sec. 10(d) of Pub. L. 92–

463, this portion of the meeting will be

closed to the public for the review,

discussion, and evaluation of grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material and

personal information concerning

individuals associated with the

applications, disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

On February 4, from 9 a.m. to 5 p.m.,

this portion of the meeting will be open

to the public for announcements and

reports of administrative, legislative,

and program developments in the drug

abuse field. Attendance by the public

will be limited to space available.

A summary of the meeting and a

roster of committee members may be

obtained from Ms. Camilla L. Holland,

NIDA Committee Management Officer,

National Institutes of Health, Parklawn

Building, Room 10–42, 5600 Fishers

Lane, Rockville, MD 20857, (301/443–

2755).

Substantive program information may

be obtained from Dr. Teresa Levitin,

Room 10–42, Parklawn Building, 5600

Fishers Lane, Rockville MD 20857, (301/

443–2755).

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Dr. Levitin in advance of the

meeting.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278, Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs)

Dated: January 8, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–1121 Filed 1–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Center

for Scientific Review Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Behavioral and

Neurosciences.

Date: January 20, 1998.

Time: 11:00 a.m.

Place: NIH, Rockledge 2, Room 5060;

Telephone Conference.

Contact Person: Dr. Samuel Rawlings,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5060, Bethesda, MD

20892, (301) 435–1243.

Name of SEP: Biological and Physiological

Sciences.

Date: January 20, 1998.

Time: 3:00 p.m.

Place: NIH, Rockledge 2, Room 4148;

Telephone Conference.

Contact Person: Dr. Philip Perkins,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4148, Bethesda, MD

20892, (301) 435–1718.

Name of SEP: Biological and Physiological.

Date: January 21, 1998.

Time: 12:00 p.m.

Place: NIH, Rockledge 2, Room 4150;

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda, MD

20892, (301) 435–1719.

Name of SEP: Biological and Physiological

Sciences.

Date: January 8, 1998.

Time: 4:00 p.m.

Place: NIH, Rockledge 2, Room 4150;

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda, MD

20892, (301) 435–1719.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Biological and Physiological

Sciences.

Date: February 22, 1998.

Time: 6:00 p.m.

Place: Hyatt Regency, Bethesda, MD.

Contact Person: Dr. Sooja Kim, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5178, Bethesda, MD 20892, (301) 435–

1780.

Name of SEP: Biological and Physiological.

Date: February 18, 1998.

Time: 11:00 a.m.

Place: NIH, Rockledge 2, Room 9112.

Contact Person: Dr. Mushtaq Khan,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4124, Bethesda, MD

20892, (301) 435–1778.

Name of SEP: Biological and Physiological

Sciences.

Date: February 23, 1998.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 6168;

Telephone Conference.

Contact Person: Dr. Syed Amir, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 6168, Bethesda, MD 20892, (301) 435–

1043.

Name of SEP: Biological and Physiological

Sciences.

Date: February 24, 1998.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 4172;

Telephone Conference.

Contact Person: Dr. Donald Schneider,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4172, Bethesda, MD

20892, (301) 435–1165.

Name of SEP: Multidisciplinary Sciences.

Date: March 18–20, 1998.

Time: 6:00 p.m.

Place: Radisson Hotel, Los Angeles, CA.

Contact Person: Dr. Bill Bunnag, Scientific

Review Administrator, 6701 Rockledge Drive,